Bill Snyder

Researchers who helped find high-risk genes for schizophrenia included, from left, Quan Wang, PhD, Bingshan Li, PhD, Nancy Cox, PhD, Rui Chen, PhD, Xue Zhong, PhD, Qiang Wei, PhD, and James Sutcliffe, PhD.
April 18, 2019

Researchers find high-risk genes for schizophrenia

Using a unique computational framework they developed, a team of scientist cyber-sleuths in the Vanderbilt University Department of Molecular Physiology and Biophysics and the Vanderbilt Genetics Institute (VGI) has identified 104 high-risk genes for schizophrenia.

By Bill Snyder
April 15, 2019

Harvard’s Christine Seidman to receive 2019 Vanderbilt Prize in Biomedical Science

Christine Seidman, MD, whose lab has identified the genetic causes of several human heart diseases including cardiomyopathy (potentially fatal enlargement of the heart) is the recipient of the 2019 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center (VUMC) announced today.

By Bill Snyder
Research by Robert Coffey, MD, left, Dennis Jeppesen, PhD, and colleagues has revealed a new way cells shed DNA into the bloodstream.
April 11, 2019

Discovery aids search for cancer biomarkers

A report by researchers at Vanderbilt University Medical Center has shattered conventional wisdom about how cells, including cancer cells, shed DNA into the bloodstream: they don’t do it by packaging the genetic material in tiny vesicles called exosomes.

By Bill Snyder
Lab manager Rachel Nargi prepares a B-cell culture during the recent “sprint” to develop an antibody-based treatment for Zika virus infection.
April 11, 2019

VUMC-led team ‘sprints’ to develop Zika virus treatment

In January scientists at Vanderbilt University Medical Center and colleagues in Boston, Seattle and St. Louis were given an audacious goal to develop — in 90 days — a protective antibody-based treatment that potentially will stop the spread of the Zika virus.

By Bill Snyder
April 11, 2019

Biostatistics expert Zeger set for next Discovery Lecture

Scott Zeger, PhD, professor of Biostatistics at the Johns Hopkins Bloomberg School of Public Health in Baltimore and a leading expert on the application of biostatistics to improve health around the world, will deliver the next Flexner Discovery Lecture on Thursday, April 18.

By Bill Snyder
March 25, 2019

VUMC joins effort to stop spread of two deadly viruses

Researchers at Vanderbilt University Medical Center are participating in a national effort to develop vaccines and other treatments as countermeasures to prevent the spread of two emerging and deadly viruses — Nipah and Hendra.

By Bill Snyder
March 15, 2019

Inaugural SCRIPS symposium set for March 21

The inaugural SCRIPS symposium — Supporting Careers in Research for Interventional Physicians and Surgeons — will be held from 1-4 p.m. March 21 in 202 Light Hall.
By Bill Snyder
March 14, 2019

New way to stimulate learning?

Vagus nerve stimulation could be beneficial for treating Alzheimer’s disease and other forms of cognitive impairment, Vanderbilt research findings suggest.
By Bill Snyder
March 14, 2019

Germ cell biology expert Lehmann set for March 21 Discovery Lecture

Ruth Lehmann, PhD, a world-renowned expert on the biology of germ cells, which generate eggs and sperm, will deliver the next Flexner Discovery Lecture on Thursday, March 21.
By Bill Snyder
March 7, 2019

Vanderbilt scientists report new modeling of brain signaling

The release of neurotransmitters and hormones in the body is tightly controlled by complex protein machinery embedded in cell membranes.
By Bill Snyder
February 28, 2019

Gene identified that increases risk of antibiotic reaction

Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.
By Bill Snyder
February 21, 2019

VUMC chikungunya antibody set to enter clinical trial

A monoclonal antibody against the chikungunya virus developed by researchers at Vanderbilt University Medical Center is the first monoclonal antibody encoded by messenger RNA to enter a clinical trial.
By Bill Snyder
1 … 47 48 49 50 51 … 110